The largest database of trusted experimental protocols

Biograph truepoint pet ct scanner

Manufactured by Siemens
Sourced in Germany

The Biograph TruePoint PET/CT scanner is a medical imaging device developed by Siemens. It combines positron emission tomography (PET) and computed tomography (CT) technologies to provide high-quality, three-dimensional images of the human body. The scanner is designed to assist healthcare professionals in the diagnosis and monitoring of various medical conditions.

Automatically generated - may contain errors

7 protocols using biograph truepoint pet ct scanner

1

PET Imaging Protocol for Cognitive Disorders

Check if the same lab product or an alternative is used in the 5 most similar protocols
PET images were acquired following European guidelines (Varrone et al., 2009 (link)). Images were obtained in a Siemens Biograph True Point PET-CT scanner that integrates a 6-detector CT with a late-generation PET using lutetium oxyorthosilicate crystals. Patients fasted for at least 6 h before the scan. 18F-FDG (185 MBq) was administered intravenously 30 min before acquisition of images. During this period of time, patients remained at sensory rest. CT scan parameters were: kVp/effective mAs/rotation: 130/40/1; slice thickness: 3 mm; reconstruction interval: 1.5 mm; and pitch: 0.75. For PET acquisition, one bed position was obtained, and the acquisition time was 10 min.
Images were preprocessed using Statistical Parametric Mapping 8 software (https://www.fil.ion.ucl.ac.uk/spm/). They were realigned, and normalized to the Montreal Neurological Institute standard space using a specific FDG-PET template for cognitive disorders (Della Rosa et al., 2014 (link)). Global mean normalization was performed individually. Marsbar software was used to perform a region of interest analysis of 116 brain areas of the Automatic Anatomical Labeling atlas belonging to the whole brain. Thus, mean uptake values were obtained for each participant in 116 regions of interest.
+ Open protocol
+ Expand
2

PET/CT Imaging of Bone Marrow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intravenous 0.1 mCi/kg 18F-FDG was administered to each patient following 6 hours of fasting, with a blood glucose level below 200 mg/dL. The intravenous/oral contrast agent was administered. After 45-60 minutes of waiting period, PET/CT images were acquired from the vertex to the upper thigh with Siemens Biograph True Point PET/CT scanner (CT section thickness 3 mm, 110 mAs, 120 kV; 3 minutes per-bed PET) (Siemens, Erlangen, Germany) at the PET/CT unit. Attenuation corrected PET, CT and fusion PET/CT images were reviewed simultaneously; visual and semiquantitative assessments were performed. The maximum standard uptake value (SUVmax) was the quantitative parameter used for 18F-FDG-PET scan. In visual assessment, bone marrow metabolic activity that is greater than the liver was considered to be pathologic. For semiquantitative assessment, regions of interest (ROI) were drawn for SUVmax estimation, which included iliac crest in cases with diffusely increased metabolic activity and the highest activity area in cases with focal involvement.
+ Open protocol
+ Expand
3

In Vivo PET Imaging of TSPO with [11C]PBR28

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects then received a bolus injection of [11C]PBR28 (mean Mbq activity ±SD: 325.31 ± 27.03) followed by a 90-minute emission scan using a Siemens Biograph™ TruePoint™ PET-CT scanner (Siemens Medical Systems, Germany). A computer tomography (CT) scan was also acquired for attenuation and scatter correction. Images were reconstructed using filtered back projection and binned into 26 frames of increasing time length (durations: 8 x 15 s, 3 x 1 min, 5 x 2 min, 5 x 5 min, 5 x 10 min). During the PET acquisition, arterial blood data were sampled via the radial artery using a combined automatic-manual approach. A continuous (one sample per second) sampling system (ABSS Allogg, Mariefred, Sweden) measured whole blood activity for the first 15 minutes of each scan. Discrete blood samples manually withdrawn at 5, 10, 15, 20, 25, 30, 40, 50, 60, 70, 80, 90 minutes, were centrifuged to determine the plasma over blood activity ratio and filtered using HPLC to calculate the plasma fraction of authentic tracer free of metabolites (Tonietto et al., 2015 (link); Tonietto et al., 2016 (link)). For further details please refer to original study and its supplementary material (Bloomfield et al., 2016b (link)).
+ Open protocol
+ Expand
4

PET/CT Imaging Procedure for Axumin

Check if the same lab product or an alternative is used in the 5 most similar protocols
18F-Fluciclovine (Axumin; Blue Earth Diagnostics, Burlington, MA) was obtained from PETNET Solutions (Culver City, CA). Patients were instructed to fast for 6 hours before examination. Approximately 3 to 5 minutes after IV administration of 10 mCi 18F-fluciclovine, PET/CT was performed on a Siemens Biograph TruePoint PET/CT scanner (Siemens, Munich, Germany). Single time point PET data were obtained using 4-minute static acquisitions in 5 bed positions starting with the pelvis, and images were reconstructed using the TrueX reconstruction algorithm. Low-dose CT images were obtained over the same anatomic range and reconstructed at 3-mm slice thickness.
+ Open protocol
+ Expand
5

PET/CT Imaging of PSMA-Expressing Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
All scans were performed using a Biograph TruePoint PET/CT scanner (Siemens Healthineers), with patients receiving an intravenous injection of a mean of 184.9 MBq (±18.9 SD) of [68Ga]Ga-PSMA-11. One-hour after injection, static whole-body scans were obtained from the skull base to the upper femur.
First, CT scans were acquired, followed by PET scans, which were reconstructed using a point-spread-function–based algorithm.
Two nuclear medicine physicians analyzed the images using Hybrid 3-dimensional software (version 4.0.0; Hermes Medical Solutions), manually delineating all PSMA-expressing primary and secondary tumor lesions. The PSMA-TV was extracted from all delineated lesions analogously to the calculation of the metabolic tumor volume, and the dominant tumor fraction, contributing most to overall PSMA-TV, was defined (supplemental methods).
+ Open protocol
+ Expand
6

68 Ga-PSMA PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All 68 Ga-PSMA PET/CT scans were performed approximately 60 min following intravenous injection of 2.14 MBq 68 Ga-PSMA ( 68 Ga-Glu-CO-Lys(Ahx)-HBED-CC) per kilogram body weight with low-dose CT for anatomical localization and attenuation correction. All patients were scanned on a Siemens Biograph TruePoint PET/CT scanner (Siemens, Erlangen, Germany). Images were reconstructed with all existing corrections applied (attenuation, scatter and Point-Spread Function) using the TrueX reconstruction algorithm (4 iterations and 21 subsets) and a 3 mm Gaussian post-filter (XYZ) and voxel size 2 Â 2 Â 2 mm.
+ Open protocol
+ Expand
7

Multimodal Imaging Evaluation of Brain Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
After bolus injection of 123 I-CLINDE, dynamic SPECT images were acquired with a triple-head IRIX camera (Philips Medical) for 2.5 h as previously described (10) , and weighted mean images were generated for region analysis.
A single-frame static PET acquisition was performed 20-40 min after intravenous injection of approximately 200 MBq of 18 F-FET on a 64-slice-CT Biograph TruePoint PET/CT scanner (Siemens). All PET scans were attenuation-corrected using low-dose CT performed immediately before the PET scan and were subsequently corrected for scatter and dead time. Images were reconstructed with an orderedsubsets expectation maximization 3-dimensional algorithm (6 itera-tions, 16 subsets) and a 5-mm gaussian filter. All patients fasted for at least 6 h before 18 F-FET injection.
T1-weighted MR imaging was performed on a 3-T MR Verio scanner (Siemens). Gadolinium was used in a dose of 0.1 mmol/kg of body weight (Multihance [Bracco] or Gadovist [Schering]). Patient 3 was rescanned using a CT scanner (Siemens) and a CT contrast agent containing 70 mL of iodine (350 mg/mL) (Omnipaque; GE Healthcare).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!